118 related articles for article (PubMed ID: 29927965)
21. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.
Jeppesen E; Brurberg KG; Vist GE; Wedzicha JA; Wright JJ; Greenstone M; Walters JA
Cochrane Database Syst Rev; 2012 May; (5):CD003573. PubMed ID: 22592692
[TBL] [Abstract][Full Text] [Related]
22. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
23. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
Baines KJ; Fu JJ; McDonald VM; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
[TBL] [Abstract][Full Text] [Related]
24. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease.
Chen Y; Shergis JL; Wu L; Yu X; Zeng Q; Xu Y; Guo X; Zhang AL; Xue CC; Lin L
Complement Ther Med; 2016 Dec; 29():94-108. PubMed ID: 27912964
[TBL] [Abstract][Full Text] [Related]
25. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
[TBL] [Abstract][Full Text] [Related]
26. Predictors of chronic obstructive pulmonary disease exacerbations.
Ishii T; Kida K
Curr Opin Pulm Med; 2014 Mar; 20(2):138-45. PubMed ID: 24406871
[TBL] [Abstract][Full Text] [Related]
27. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
28. [Acute exacerbations of chronic obstructive pulmonary disease].
Chabot F; Gomez E; Guillaumot A; Kheir A; Chaouat A
Presse Med; 2009 Mar; 38(3):485-95. PubMed ID: 19185446
[TBL] [Abstract][Full Text] [Related]
29. Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS).
Celli B; Halpin D; Hepburn R; Byrne N; Keating ET; Goldman M
Respir Med; 2003 Jan; 97 Suppl A():S35-43. PubMed ID: 12564609
[TBL] [Abstract][Full Text] [Related]
30. Informal caregiving in COPD: A systematic review of instruments and their measurement properties.
Cruz J; Marques A; Machado A; O'Hoski S; Goldstein R; Brooks D
Respir Med; 2017 Jul; 128():13-27. PubMed ID: 28610666
[TBL] [Abstract][Full Text] [Related]
31. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.
Doll H; Miravitlles M
Pharmacoeconomics; 2005; 23(4):345-63. PubMed ID: 15853435
[TBL] [Abstract][Full Text] [Related]
32. Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens.
Younossi Z; Henry L
Aliment Pharmacol Ther; 2015 Mar; 41(6):497-520. PubMed ID: 25616122
[TBL] [Abstract][Full Text] [Related]
33. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure.
Leidy NK; Wilcox TK; Jones PW; Murray L; Winnette R; Howard K; Petrillo J; Powers J; Sethi S;
Value Health; 2010 Dec; 13(8):965-75. PubMed ID: 20659270
[TBL] [Abstract][Full Text] [Related]
34. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
35. A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.
Vishweswaraiah S; George L; Purushothaman N; Ganguly K
Respir Res; 2018 Jun; 19(1):92. PubMed ID: 29871630
[TBL] [Abstract][Full Text] [Related]
36. Examining genetic susceptibility in acute exacerbations of COPD.
Wan ES
Thorax; 2018 Jun; 73(6):507-509. PubMed ID: 29317548
[No Abstract] [Full Text] [Related]
37. PRO (Patient Reported Outcomes) Implementation: From Vision to Reality.
Galper A; Shamai-Rosler O; Stanger V; Zimlichman E
Stud Health Technol Inform; 2019 Aug; 264():1839-1840. PubMed ID: 31438369
[TBL] [Abstract][Full Text] [Related]
38. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.
Sprangers MA; Sloan JA; Veenhoven R; Cleeland CS; Halyard MY; Abertnethy AP; Baas F; Barsevick AM; Bartels M; Boomsma DI; Chauhan C; Dueck AC; Frost MH; Hall P; Klepstad P; Martin NG; Miaskowski C; Mosing M; Movsas B; Van Noorden CJ; Patrick DL; Pedersen NL; Ropka ME; Shi Q; Shinozaki G; Singh JA; Yang P; Zwinderman AH
Twin Res Hum Genet; 2009 Jun; 12(3):301-11. PubMed ID: 19456223
[TBL] [Abstract][Full Text] [Related]
39. Exacerbations in Chronic Obstructive Pulmonary Disease: Clinical, Genetic, and Mycobiome Risk Factors.
Matsumoto K; Read N; Philip KEJ; Allinson JP
Am J Respir Crit Care Med; 2023 Aug; 208(4):487-489. PubMed ID: 37104845
[No Abstract] [Full Text] [Related]
40. For each hypothesis on the aetiology of Beethoven's hearing disorder, there remain pro's and con's.
Thomas JP; Dazert S; Prescher A; Voelter C
Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):5111-5112. PubMed ID: 34623499
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
